3 Reasons TFX is Risky and 1 Stock to Buy Instead

Over the last six months, Teleflex’s shares have sunk to $113.26, producing a disappointing 13% loss - a stark contrast to the S&P 500’s 4.8% gain. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Is now the time to buy Teleflex, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Do We Think Teleflex Will Underperform?

Even with the cheaper entry price, we're cautious about Teleflex. Here are three reasons why TFX doesn't excite us and a stock we'd rather own.

1. Revenue Spiraling Downwards

Reviewing a company’s long-term sales performance reveals insights into its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul. Over the last five years, Teleflex’s demand was weak and its revenue declined by 4.8% per year. This was below our standards and is a sign of poor business quality.

2. Weak Constant Currency Growth Points to Soft Demand

Investors interested in Surgical Equipment & Consumables - Specialty companies should track constant currency revenue in addition to reported revenue. This metric excludes currency movements, which are outside of Teleflex’s control and are not indicative of underlying demand.

Over the last two years, Teleflex’s constant currency revenue averaged 3.7% year-on-year growth. This performance slightly lagged the sector and suggests it might have to lower prices or invest in product improvements to accelerate growth, factors that can hinder near-term profitability.

3. Free Cash Flow Margin Dropping

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

As you can see below, Teleflex’s margin dropped by 20.6 percentage points over the last five years. If its declines continue, it could signal increasing investment needs and capital intensity. Teleflex’s free cash flow margin for the trailing 12 months was breakeven.

Final Judgment

Teleflex falls short of our quality standards. After the recent drawdown, the stock trades at 17.2× forward P/E (or $113.26 per share). This multiple tells us a lot of good news is priced in - you can find more timely opportunities elsewhere. We’d recommend looking at the Amazon and PayPal of Latin America.

High-Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.